A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

To overcome some of the pitfalls with dexmedetomidine as the sole agent, there are an increasing number of reports regarding its combination with ketamine. This article provides a descriptive ...

These are usually derivatives of "classic" psychoactive substances, including medications. An example of such a substance is ...

In 2019, the U.S. Food and Drug Administration (FDA) approved the use of a nasal spray ketamine derivative called esketamine (Spravato) to treat depression in adults, according to the National ...

Once sidelined in the 1970s, psychedelic substances—ranging from esketamine (a ketamine derivative) and psilocybin (the active ingredient in hallucinogenic mushrooms) to MDMA—are being reintroduced as ...